AEON Biopharma, Inc. (AEON)
0.1603
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:37
AEON Biopharma Shareholders Equity (Quarterly) : -15.36M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.36M |
| March 31, 2026 | -16.75M |
| December 31, 2025 | -55.03M |
| September 30, 2025 | -19.87M |
| June 30, 2025 | -15.85M |
| March 31, 2025 | -11.32M |
| December 31, 2024 | -28.57M |
| September 30, 2024 | -32.09M |
| June 30, 2024 | -27.95M |
| March 31, 2024 | -198.38M |
| December 31, 2023 | -92.33M |
| September 30, 2023 | -67.69M |
| Date | Value |
|---|---|
| June 30, 2023 | 9.732M |
| March 31, 2023 | 13.67M |
| December 31, 2022 | -149.55M |
| September 30, 2022 | 265.35M |
| June 30, 2022 | 263.71M |
| March 31, 2022 | 261.84M |
| December 31, 2021 | 259.07M |
| September 30, 2021 | 258.82M |
| June 30, 2021 | 253.16M |
| March 31, 2021 | 257.16M |
| December 31, 2020 | 0.0214M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.91M |
| Total Liabilities (Quarterly) | 21.27M |
| Debt to Equity Ratio | -0.1807 |
| Current Ratio | 0.5439 |
| Net Debt Paydown Yield | 12.50% |